1. A multicentre study of the risk factors associated with recurrence of central serous chorioretinopathy
- Author
-
Xiaoyin Zhou, Yuki Komuku, Takashi Araki, Kenta Hozumi, Hiroto Terasaki, Akiko Miki, Soichiro Kuwayama, Masanori Niki, Hisashi Matsubara, Takamasa Kinoshita, Tomo Nishi, and Fumi Gomi
- Subjects
Male ,Adult ,Choroid ,General Medicine ,Middle Aged ,Fluoresceins ,Ophthalmology ,Central Serous Chorioretinopathy ,Risk Factors ,Humans ,Female ,Fluorescein Angiography ,Tomography, Optical Coherence ,Aged ,Retrospective Studies - Abstract
To investigate potential clinical and multimodal imaging factors in central serous chorioretinopathy (CSC) recurrence.The study was performed at nine Japanese medical institutions for patients who had experienced an active CSC episode. Demographic data and medical history were reviewed retrospectively. Significant differences in chronic manifestation, leakage site, leakage point number, leakage intensity, choroidal hyperpermeability, central retinal thickness (CRT) and subfoveal choroidal thickness were analysed between the recurrence and non-recurrence groups.In total, 538 eyes (538 patients) diagnosed with CSC (402 men, 136 women; mean age: 53.4 ± 11.9 years) were enrolled. Among them, 253 eyes (47.0%) developed ≥1 recurrence (follow-up: 15.9 ± 13.5 months, range 3-86 months). Univariate and multivariate analyses indicated that a history of corticosteroid use (odds ratio [OR], 5.52; 95% confidence interval [CI], 1.39-21.92; p = 0.015), bilateral disease (OR, 3.94; 95% CI, 1.47-10.6; p = 0.007), chronic manifestations (OR, 7.12; 95% CI, 2.93-17.28; p 0.001), non-intense fluorescein leakage (OR, 3.34; 95% CI, 1.44-7.75; p = 0.005) and initial CRT (OR, 0.997; 95% CI, 0.993-0.999; p = 0.049) were significantly associated with CSC recurrence. Receiver operating characteristic curves were created, and the area under the curve for the multivariate logistic regression model of these five factors was 0.814.Patients with CSC who received corticosteroids and had bilateral disease, chronic manifestation, non-intense fluorescein leakage on fluorescein angiography or a relatively thinner CRT should be closely monitored to identify whether they are at high risk of recurrence.
- Published
- 2022